Brokerages Set Kyverna Therapeutics, Inc. (NASDAQ:KYTX) PT at $18.40
Kyverna Therapeutics, Inc. (NASDAQ:KYTX – Get Free Report) has been assigned a consensus recommendation of “Buy” from the seven research firms that are presently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation, five have assigned a buy recommendation and one has issued a strong buy recommendation on […]
Kyverna Therapeutics, Inc. (NASDAQ:KYTX – Get Free Report) has been assigned a consensus recommendation of “Buy” from the seven research firms that are presently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation, five have assigned a buy recommendation and one has issued a strong buy recommendation on […]